How do you know if a “positive” study is positive? And what if clinical trial participants unionized?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we dig into Biogen’s much-dissected data on a treatment for Alzheimer’s disease, with on-the-ground takes from experts at a scientific conference. Then, STAT’s Eric Boodman joins us to spin a drug-discovery yarn involving one-eyed sheep, Basque farmers, and the quest to treat a rare form of cancer.

For more on what we cover, here’s the Biogen news, and here’s the story on the hunt for a new medicine.

advertisement

We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email readoutloud@statnews.com.

advertisement


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at marketing@statnews.com.

  • Please redirect my Stat posts, newsletters, etc. to my email address rather than Facebook. Thanks.

  • I live in Singapore, age 70 and via brain scan found to have amyloid protein in my brain hence my upmost concern and worries and would appreciate any comments or useful feedback

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy